GovChime
AWARDDEFINITIVE CONTRACTOther than small business

Definitive contract 75F40119C10161LOVELACE BIOMEDICAL RESEARCH INSTITUTE

Overview

Award facts

Net obligations
$38.81M
$38,812,829of $38.81M potential value
Outlays (paid to date)
$18.71M
$18.71M paid of $38.81M obligated$18,710,374
Period of performance
Sep 26, 2019 to Jun 30, 2025
Ended
Modifications
9
Latest action Jun 16, 2026
Contract type
Definitive contract
PIID 75F40119C10161

Contract value is the most the government could spend; obligations are what it has legally committed; outlays are what it has actually paid.

Description of requirement

STUDY OF E-CIGARETTE AEROSOL TOXICITY IN IN VIVO NONCLINICAL MODELS.

Dates and value

Award date
Signed on Sep 26, 2019
Current value
$38,812,829Base and exercised options
Potential value (if all options are exercised)
$38,812,829

Obligations by fiscal year of action

  • FY2026: -$7,235,795 (de-obligation)
  • FY2025: $9,762,422
  • FY2019: $36,286,201

Total across 3 fiscal years: $38,812,829

Net de-obligation in that fiscal year (obligations withdrawn).

Source: Federal Procurement Data System contract actions as published by SAM.gov and USAspending.gov; latest action recorded Jun 16, 2026. View on USAspending · Recipient on SAM.gov

Recipient

LocationALBUQUERQUE, NM
UEIMBT9RXJJ7428
CAGE code3MMH4
Business sizeOther than small businessSize at award, per the contracting officer
Organization typeCorporate tax exempt

Business types and certifications

Tax-exempt corporation

As represented in SAM.gov at the time of the action.

Subcontracting network

The prime, the subcontractors on this award, and their own subcontractors.

Subaward amounts are self-reported by prime contractors to SAM.gov and appear 1 to 2 months after the work. Duplicates are removed on a best-effort basis. Totals are incomplete and not an audit. Source: USAspending.

Agency and place

Awarding and funding

Funded by
  1. Department of Health and Human Services
  2. Food And Drug Administration
  3. FDA OFFICE OF ACQ GRANT SVCS
Funded from
Foods; Human drugs; Devices and radiological health; National center for toxicological research; Fda other activities (fda headquaters); Animal drugs and feed; Biologics; Fda user fees (non general fund)Program activities075-0600Federal accounts (agency financial reports)

Place of performance

Place of performance
Silver Spring, Montgomery County, Maryland 20903-1057
Congressional district (place of performance)
MD-04As reported at the time of the action

Classification and competition

Classification

Competition

Extent competed
Full and open competitionA
Solicitation procedures
Negotiated proposal/quoteNP
Set-aside
No set-aside used
Contract pricing
Firm fixed priceJ
Offers received
1

Solicitation and notices

Solicitation ID
FDA19SOL1207956(as reported)
Solicitation date
Aug 21, 2018

Contract details

Subcontracting plan
Individual subcontract planF
Cost Accounting Standards clause
Not applicable exempt from CASX
Certified cost or pricing data
No
Commercial procedures
Commercial products/servicesA
Government-furnished property
Transaction does not use GFE/GFPN
Bundled requirement
Not bundledH
Consolidated requirement
Not consolidatedD
Undefinitized action (terms not final)
No
Multi-year contract
No
Performance-based service acquisition
No - service where PBA is not used.N

Linked notices

Notice
Notice ID
Type
Link
Posted

Transaction history

Modification history

Base award
Sep 26, 2019Base obligation at award: $36,286,201
Latest action
Jun 16, 2026 — CloseoutModification P00009; obligation change -$7,235,795; administrative: no change in scope or value
Latest substantive action
Nov 24, 2021 — Supplemental agreement (within scope)Modification P00004
Actions by type
  • Base award1
  • Other administrative action6
  • Supplemental agreement (within scope)1
  • Novation (contract transferred)1
  • Closeout1
10 actions recorded, Sep 26, 2019 to Jun 16, 2026; each action counted once.

Similar awards

PIID
Match
Awardee

All contract data

All contract data

Every other field reported for this award, as of its latest reported action

Competition

Evaluation preference
No preference used
Local area set-aside
No
Synopsized publicly (SAM.gov / FedBizOpps)
Yes
Simplified procedures for commercial items
No
A-76 (FAIR Act) action
No

Pricing and financing

Paid by purchase card
No
Latest action: change in base and exercised options
-$7,235,795
Latest action: change in base and all options
-$7,235,795

Socio-economic and policy

Inherently governmental functions
Other functionsOT
Recovered materials and sustainability
No clauses included and no sustainability includedC
EPA-designated product
Not requiredE
Clinger-Cohen Act planning (IT)
No

Place and origin

Domestic or foreign entity
U.S. owned businessA
Country of product or service origin
United statesUSA
Place of manufacture
Not a manufactured end productC

Structure

Award or IDV
Award
Award type
Definitive contractD
Awarding agency code
7500
Awarding sub-tier code
7524
Contracting office code
75F401
Transactions recorded under this award key
10

Funding

Funding agency code
7500
Funding sub-tier code
7524
Funding office code
75F401
Treasury accounts
  • 075-2019/2019-0600-000
  • 075-X-0600-000
Object classes
  • 25.1: Advisory and assistance services
Disaster or emergency funding (DEFC)
  • Q: Not Designated Nonemergency/Emergency/Disaster/Wildfire Suppression